MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
586.49%
Quick Ratio
586.49%
Cash Ratio
534.64%
Debt to Asset Ratio
17.04%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Deferred offering costs
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
19,985,000
2,950,877
7,201,014
9,864,087
Deferred offering costs
73,000
27,248
45,486
43,700
Subscription receivable
-
-
0
0
Prepaid expenses and other current assets
1,865,000
1,100,214
856,301
1,483,948
Total current assets
21,923,000
4,078,339
8,102,801
11,391,735
Prepaid expenses, net of current portion
0
552,839
502,962
474,416
Property and equipment, net
15,000
22,014
17,703
3,107
Total noncurrent assets
15,000
574,853
520,665
477,523
Total assets
21,938,000
4,653,192
8,623,466
11,869,258
Accounts payable and accrued expenses
3,738,000
4,350,134
3,772,339
1,928,324
Notes payable
0
232,353
328,571
30,793
Total current liabilities
3,738,000
4,582,487
4,100,910
1,959,117
Total liabilities
3,738,000
4,582,487
4,100,910
1,959,117
Common stock, 0.001 par value, 300,000,000 shares authorized at june 30, 2026 and december 31, 2025 and 1,461,449 and 632,516 shares issued and outstanding at june 30, 2026 and december 31, 2025
2,000
811
633
574
Additional paid-in capital
125,998,000
105,282,208
104,797,191
104,229,033
Accumulated deficit
-107,800,000
-105,212,314
-100,275,268
-94,319,466
Total stockholders' equity
18,200,000
70,705
4,522,556
9,910,141
Total liabilities and stockholders' equity
21,938,000
4,653,192
8,623,466
11,869,258
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$19,985,000 (64.76%↑ Y/Y)Prepaid expenses andother current assets$1,865,000 (-6.46%↓ Y/Y)Deferred offering costs$73,000 (415.06%↑ Y/Y)Property and equipment,net$15,000 (294.32%↑ Y/Y)Total current assets$21,923,000 (55.07%↑ Y/Y)Total noncurrentassets$15,000 (-95.95%↓ Y/Y)Total assets$21,938,000 (51.21%↑ Y/Y)Total liabilities andstockholders' equity$21,938,000 (51.21%↑ Y/Y)Total stockholders'equity$18,200,000 (38.67%↑ Y/Y)Total liabilities$3,738,000 (170.30%↑ Y/Y)Accumulated deficit-$107,800,000 (-18.33%↓ Y/Y)Additional paid-in capital$125,998,000 (20.89%↑ Y/Y)Total currentliabilities$3,738,000 (170.30%↑ Y/Y)Common stock, 0.001 parvalue, 300,000,000...$2,000 (296.83%↑ Y/Y)Accounts payable andaccrued expenses$3,738,000 (196.40%↑ Y/Y)

CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals, Inc. (CNSP)